Takeshi Saino – Kawasumi Laboratories

More recent news

• Bausch + Lomb is returning recalled intraocular lenses to the market
• Neuralink reportedly expects to raise $500M at $8.5B valuation
• ResMed posts Street-beating Q3
• Edwards posts Street-beating Q1 results, ups 2025 sales guidance
• Data backs Boston Scientific drug-eluting stent